Header cover image

Capital Goods Healthcare Sector

Results

2303

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2303 companies

Regen BioPharma

Market Cap: US$1.1m

Focuses on the development of regenerative medical applications in the United States.

RGBP

US$0.042

7D

-31.5%

1Y

-91.7%

CYduct Diagnostics

Market Cap: US$1.1m

A healthcare instrument company, develops and markets technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment, and management of disease and medical conditions.

CYDX

US$0.20

7D

0%

1Y

-33.4%

Trevena

Market Cap: US$1.1m

A biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders.

TRVN

US$1.14

7D

4.6%

1Y

-88.4%

TransCanna Holdings

Market Cap: CA$1.4m

Through its subsidiaries, engages in the manufacturing, transportation, and distribution of cannabis related products in the United States.

TCAN

CA$0.01

7D

0%

1Y

-90.0%

Entheon Biomedical

Market Cap: CA$1.5m

Operates as a biotechnology research and development company.

ENBI

CA$0.11

7D

4.8%

1Y

-35.3%

TruSpine Technologies

Market Cap: UK£765.1k

A medical device company, engages in the development of spinal stabilization products in the United Kingdom and the United States.

TSP

UK£0.005

7D

0%

1Y

-81.8%

Braxia Scientific

Market Cap: CA$1.4m

Operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders.

BRAX

CA$0.005

7D

0%

1Y

-50.0%

Street Capital

Market Cap: CA$1.4m

Focuses on the production and sale of cannabis-based hashish and other cannabis products in Canada.

STRC.X

CA$0.005

7D

0%

1Y

0%

Terranueva

Market Cap: CA$1.4m

Terranueva Corporation intends to produce cannabis for medical and recreational purposes.

TEQ

n/a

7D

n/a

1Y

n/a

Waverley Pharma

Market Cap: CA$1.4m

A biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom, European Union and North America.

WAVE

CA$0.015

7D

50.0%

1Y

-40.0%

Adastra Holdings

Market Cap: CA$1.3m

Adastra Holdings Ltd. extracts and processes cannabis for recreational and medical markets in Canada.

XTRX

CA$0.24

7D

-15.8%

1Y

-88.0%

Wellfully

Market Cap: AU$1.5m

Wellfully Limited, together with its subsidiaries, focuses on the development and commercialization of Dermaportation and ETP transdermal drug delivery technologies.

WFL

AU$0.003

7D

0%

1Y

-87.0%

Brain Scientific

Market Cap: US$932.0k

Brain Scientific Inc., a medtech company, provides neurology and motion products in the United States and internationally.

BRSF

US$0.75

7D

0%

1Y

-92.4%

PPJ Healthcare Enterprises

Market Cap: US$920.5k

Through its subsidiaries, provides automated healthcare reimbursement cycle, online health information digital-systems, and practice information management digital-system software to health care providers and general businesses worldwide.

PPJE

US$0.000001

7D

0%

1Y

-99.3%

CBD Life Sciences

Market Cap: US$918.7k

Engages in the development and marketing a line of cannabidiol based organic products.

CBDL

US$0.00025

7D

-16.7%

1Y

-96.4%

Iconic Labs

Market Cap: UK£669.7k

Does not have significant operations.

ICON

UK£0.06

7D

160.9%

1Y

n/a

WOWI

Market Cap: US$900.0k

An early-stage company, engages in the business of licensing technology and intellectual property to operators and businesses in the legal cannabis industry in the United States.

WOWU

US$0.027

7D

0%

1Y

n/a

NanoVibronix

Market Cap: US$896.0k

Through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing, and administration at home without the assistance of medical professionals.

NAOV

US$0.86

7D

-27.5%

1Y

-89.9%

Justera Health

Market Cap: CA$1.2m

Operates as a health and wellness management company in Canada.

VTAL

CA$0.005

7D

0%

1Y

-50.0%

Plandaí Biotechnology

Market Cap: US$888.9k

Focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries.

PLPL

US$0.0001

7D

9,900.0%

1Y

-75.0%

Psyence Group

Market Cap: CA$1.2m

A life science biotechnology company, engages in the cultivation and production of commercial psilocybin mushroom.

PSYG

CA$0.13

7D

-13.3%

1Y

-65.3%

EV Biologics

Market Cap: US$880.4k

A biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics.

YECO

US$0.086

7D

0%

1Y

-84.5%

Lifeline Biotechnologies

Market Cap: US$869.8k

Operates as a medical technology company in the United States.

LLBO

US$0.0004

7D

33.3%

1Y

0%

ViaDerma

Market Cap: US$863.6k

Operates as a specialty pharmaceutical company in the United States.

VDRM

US$0.0007

7D

0%

1Y

-90.0%

RAMM Pharma

Market Cap: CA$1.2m

Engages in the pharmaceutical and medical product business in Uruguay, Italy, and Poland.

RAMM

CA$0.01

7D

0%

1Y

-60.0%

Dynatronics

Market Cap: US$861.2k

A medical device company, designs, develops, manufactures, markets, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States, Asia, Latin America, the Middle East, and internationally.

DYNT

US$0.081

7D

0%

1Y

-79.2%

Emmaus Life Sciences

Market Cap: US$849.4k

A commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally.

EMMA

US$0.013

7D

2.3%

1Y

-85.6%

AdAlta

Market Cap: AU$1.3m

A clinical stage biotechnology company, discovers and develops protein and cell-based therapeutics by its i-body platform in Australia.

1AD

AU$0.002

7D

-33.3%

1Y

-92.0%

SQZ Biotechnologies

Market Cap: US$825.8k

A clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions.

SQZB

US$0.028

7D

0%

1Y

-43.7%

MediXall Group

Market Cap: US$800.9k

Provides health solutions in the United States.

MDXL

US$0.0039

7D

0%

1Y

n/a

Panacea Life Sciences Holdings

Market Cap: US$792.7k

Operates as a holding company, develops, manufactures, research, produces, and distributes hemp-derived cannabinoid, functional mushroom, Kratom, plant-based ingredients, and nutraceutical products for consumers and pets.

PLSH

US$0.037

7D

2.0%

1Y

-74.8%

LadRx

Market Cap: US$787.2k

A biopharmaceutical company, engages in research and development of chemotherapeutic drugs for solid tumors in the United States.

LADX

US$1.59

7D

0%

1Y

-45.2%

Avenue Therapeutics

Market Cap: US$786.8k

A specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases.

ATXI

US$0.26

7D

18.1%

1Y

-93.0%

UA Multimedia

Market Cap: US$781.6k

A media company, engages in Web, mobile applications, and film production and distribution activities.

UAMM

US$0.0024

7D

-4.0%

1Y

-0.2%

Hepion Pharmaceuticals

Market Cap: US$779.3k

A biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC) and other chronic liver diseases in the United States.

HEPA

US$0.065

7D

-15.8%

1Y

-99.9%

Pharmadrug

Market Cap: CA$1.1m

Operates as a specialty pharmaceutical company.

PHRX

CA$0.01

7D

0%

1Y

-66.7%

Page 50 of 64